The CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
CD28 and CTLA-4 are related members of a family of T lymphocyte cell surface receptors that function to regulate T cell activation. We have found that the cytoplasmic domains of both CTLA-4 and CD28 can associate with members of the PP2A family of serine/threonine phosphatases. The association of PP2A with CD28 was negatively regulated by tyrosine phosphorylation of the CD28 cytoplasmic domain. Inhibition of PP2A activity in Jurkat leukemia T cells by treatment with okadaic acid or by expression of a dominant-negative mutant enhanced T cell activation induced by CD28 engagement. Interactions between cell surface receptors such as CTLA-4 and CD28 and serine/threonine phosphatases may represent a novel mechanism for modulating the intracellular signal transduction pathways associated with cell activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CTLA-4 inhibits T cell activity through both T cell-intrinsic and T cell-extrinsic mechanisms.”
From Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance (2021) · cites this paper as [9]
In the citing paper
“PP2A has also been reported to associate with CD28 and CTLA-4 (Chuang et al., 2000). GST pulldowns from HEK293 cells have shown that the cytoplasmic domains of CTLA-4 and CD28 can interact with PP2A/C.”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Chuang et al., 2000
Citations
Cites
THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASES
Cohen, P. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002321 · Cited by 2,524
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210
Self-citationJNK is involved in signal integration during costimulation of T lymphocytes
Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M., & Ben-Neriah, Y. (1994) · Cell · doi:10.1016/0092-8674(94)90056-6 · Cited by 906
Frangioni, J. V., & Neel, B. G. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1170 · Cited by 879
Regulation of protein kinase cascades by protein phosphatase 2A
Millward, T. A., Zolnierowicz, S., & Hemmings, B. A. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01375-4 · Cited by 793
Molecular Basis of T Cell Inactivation by CTLA-4
Lee, K.-M., Chuang, E., Griffin, M., Khattri, R., Hong, D. K., Zhang, W., Straus, D., Samelson, L. E., Thompson, C. B., & Bluestone, J. A. (1998) · Science · doi:10.1126/science.282.5397.2263 · Cited by 684
Self-citationThe Emerging Role of CTLA-4 as an Immune Attenuator
Thompson, C. B., & Allison, J. P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80366-0 · Cited by 634
Self-citationRegulation of T Cell Receptor Signaling by Tyrosine Phosphatase SYP Association with CTLA-4
Marengère, L. E. M., Waterhouse, P., Duncan, G. S., Mittrücker, H.-W., Feng, G.-S., & Mak, T. W. (1996) · Science · doi:10.1126/science.272.5265.1170 · Cited by 551
Sontag, E., Fedorov, S., Kamibayashi, C., Robbins, D., Cobb, M., & Mumby, M. (1993) · Cell · doi:10.1016/0092-8674(93)90533-v · Cited by 510
Novel protein serine/threonine phosphatases: Variety is the spice of life
Cohen, P. T. W. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01060-8 · Cited by 505
Research works printed but not linked: 1
- Richards, 1992, Inhibition of the serine/threonine protein phosphatases PP1 and PP2A in lymphocytes, Immunology, 76, 642
Cited by
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0306-5 · Cited by 4,154
Bagchi, S., Yuan, R., & Engleman, E. G. (2021) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042020-042741 · Cited by 2,189
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
“To this end the cytoplasmic domain of CTLA-4 has been reported to interact with the tyrosine phosphatase SHP-2 (40) and serine/threonine phosphatase PP2A (17).”
BackgroundInfluentialSelf-citationThe CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475
Self-citationImmune checkpoint signaling and cancer immunotherapy
He, X., & Xu, C. (2020) · Cell Research · doi:10.1038/s41422-020-0343-4 · Cited by 1,371
Metadata
- Authors
- Chuang, E., Fisher, T. S., Morgan, R. W., Robbins, M. D., Duerr, J. M., Vander Heiden, M. G., Gardner, J. P., Hambor, J. E., Neveu, M. J., & Thompson, C. B.
- Affiliations
- Cornell University (US)
- Pfizer (United States) (US)
- University of Chicago (US)
- Corresponding author
- Thompson, Craig B.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2000-09
- Volume
- 13
- Issue
- 3
- Pages
- 313-322
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2065633276
- Cited by
- 303
- References
- 51
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 14 · 2023: 9 · 2022: 15 · 2021: 15 · 2020: 17 · 2019: 13 · 2018: 15 · 2017: 11 · 2016: 12 · 2015: 11 · 2014: 14 · 2013: 11 · 2012: 10
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 587 d)
- Locations
- Immunity (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Abramson Cancer Center
- National Institutes of Health (5k08ca078591-06)
- National Cancer Institute (K08 CA78591)
- National Institute of Allergy and Infectious Diseases (P01 AI352942)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- CD28, CTLA-4, protein phosphatase 2A, serine/threonine phosphatase, T cell activation, tyrosine phosphorylation, receptor cytoplasmic domain, okadaic acid, dominant-negative mutant, signal transduction
- MeSH terms
- Abatacept, Amino Acid Sequence, Antigens, Differentiation, Cell Line, Cytoplasm, Enzyme Activation, Humans, Interleukin-2, Molecular Sequence Data, Peptide Fragments, Phosphoprotein Phosphatases, Receptors, Cell Surface, T-Lymphocytes, Down-Regulation, Antigens, CD, Protein Structure, Tertiary, CD28 Antigens, Immunoconjugates, Jurkat Cells, Okadaic Acid, Lymphocyte Specific Protein Tyrosine Kinase p56(lck), Holoenzymes, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A. https://app.cochat.ai/papers/10.1016/s1074-7613(00)00031-5
- The paper
- Chuang, E., Fisher, T. S., Morgan, R. W., Robbins, M. D., Duerr, J. M., Vander Heiden, M. G., Gardner, J. P., Hambor, J. E., Neveu, M. J., & Thompson, C. B. (2000). The CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A. Immunity. https://doi.org/10.1016/s1074-7613(00)00031-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.